Curriculum Vitae

Richard T. Scott, MD, HCLD

View the video introduction to Dr. Scott's presentation in Windows Media or  RealMedia
View Dr. Scott's  presentation 
Read the written transcript of Dr. Scott's video introduction
Read the written transcript of Dr. Scott's presentation
access the printable version of this page



Reproductive Medicine Associates (RMA)
111 Madison Ave, Suite 100
Morristown, New Jersey 07931
973-656-2831
Email address: rscott@rmanj.com 

Dr. Scott, a board certified reproductive endocrinologist, is one of the founding partners of Reproductive Medicine Associates. He is one of a select few physicians who are board certified by the American Board of Bioanalysis as an embryologist, andrologist, and high complexity clinical laboratory director. This multidiscipline certification makes him uniquely suited to integrate both the clinical and laboratory services in a reproductive medicine practice. He completed his fellowship in reproductive endocrinology at the Jones Institute in Norfolk, Virginia, after receiving his medical degree from the University of Virginia Medical School. Dr. Scott is a recognized leader in the areas of ovulation induction for assisted reproduction, implantation, and ovarian reserve screening, and oocyte donation.

Dr. Scott oversees three separate embryology labs in New York, New Jersey and Connecticut, and has completed more than 15,000 in vitro fertilization (IVF) cycles. He is an award-winning researcher and author of more than 200 scientific papers and abstracts, serves as an ad hoc reviewer for more than a dozen peer review journals, and has lectured on his research to reproductive endocrinologists throughout the United States and abroad. He has received more than a dozen awards for excellence in clinical and laboratory research, and is the recipient of numerous awards from professional groups and patient advocacy associations. He serves on the Board of Directors for The American Fertility Association ( http://www.americaninfertility.org/ - AIA), a national non-profit organization assisting couples with infertility issues.

Education

• 1976-1979 - B.S.; Chemistry
  Randolph-Macon College, Ashland, Va.
• 1979-1983 - M.D. 1983
  University of Virginia School of Medicine, Charlottesville, Virginia

Postdoctoral  training

• 1983-1984 - Internship, Obstetrics and Gynecology
  Wilford Hall USAF Medical Center, San Antonio, Texas 
• 1984-1987 - Residency, Obstetrics and Gynecology
  Wilford Hall USAF Medical Center, San Antonio, Texas 
• 1987-1989 - Fellowship, Reproductive Endocrinology
  The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia
• 1993 - Aerospace Medicine (Primary)
  United States Air Force School of Aerospace Medicine, Brooks, AFB, Texas

Academic appointments

• December 1989 - June 1993 - Chief, Reproductive Endocrinology
  Department of OB/GYN, Wilford Hall Medical Center , Lackland AFB, Texas
• July 1, 1989 - June 10, 1993 - Program Director, Embryologist, and Andrologist
  Department of Defense, Assisted Reproduction Program, Wilford Hall Medical Center, Lackland AFB, Texas
• 1990 -1993 - Assistant Professor
  Uniformed Services University of the Health Sciences
• 1990 - 999 - Adjunct Scientist
  Southwest Foundation for Biomedical Research
• June 1993 -April 1995 - Chief, Reproductive Endocrinology
  Uniformed Services University of the Health Sciences, Bethesda, Maryland 
• November 1993 - June 1995 - Consultant for Reproductive Endocrinology
  Surgeon General's Office of the United States Air Force
• 1993 - 1995 - Associate Professor 
  Uniformed Services University of the Health Sciences
• 1993-1995 - Clinical Director
  Federal Fellowship in Reproductive Endocrinology
• February 1994 - June 1995 - Member
  Civilian External Peer Review Board 
• 1995 -1999 - Clinical Associate Professor
  Uniformed Services University of the Health Sciences 
• 1995-1999 - Director Assisted Reproduction Program
  Saint Barnabas Medical Center 

Hospital appointments

• 1989-1993 - Wilford Hall USAF Medical Center, San Antonio, Texas
• 1993-1995 - Walter Reed Army Medical Center, Washington D.C.
• 1993-1995 - National Naval Medical Center, Bethesda, Maryland
• 1995- Present - aint Barnabas Medical Center, Livingston, New Jersey
• 1999- Present - Morristown Memorial Hospital, Morristown, New Jersey

Specialty & subspecialty certification

• 1984 - Diplomat, National Board of Medical Examiners
• 1987 - Boarded American Board of Obstetrics & Gynecology
• 1989 - Boarded, American Board of Obstetrics & Gynecology, Division of Reproductive Endocrinology
• 1999 - Boarded, American Board of Bioanalysis
  • High Complexity Laboratory Director (HCLD)
  • Endocrinology, Andrology, and Human Embryology
• Medical license: New Jersey, New York, Connecticut

Honors & awards

• 1987 - Best Paper by Physician in Training, International Fertility Society
• 1988 - Chairman's Award, Armed Forces District Meeting of the American College of Obstetrics and Gynecology
• 1988 - First Place Abstract, Resident Category, Armed Forces District Meeting of the American College of Obstetrics and Gynecology
• 1988 - Best Poster, Annual Meeting of the American Fertility Society
• 1989 - Searle Award, Best Paper presented by a junior fellow at a district of the American College of Obstetrics and Gynecology. Presented at the Annual Clinical Meeting of the American College of Obstetrics and Gynecology
• 1991 - Professor of the Year, Presented at the Armed Forces District Meeting of the American College of Obstetrics and Gynecology, Cincinnati, Ohio.
• 1991 - Best resident paper. The Armed Forces District Meeting of the American College of Obstetrics and Gynecology, Cincinnati, Ohio. First Author - Stanton A. Bailey, M.D.
• 1993 - Chairman's Award - Best scientific paper at the Armed Forces District of the American College of Obstetrics and Gynecology, Seattle, Washington.
• 1995 - Best fellow paper. The Armed Forces District Meeting of the American College of Obstetrics and Gynecology, San Diego, California. First Author - Bradley T. Miller, M.D.
• 1996 - General Program Prize Paper, The American Society for Reproductive Medicine, Boston Massachusetts, November 2-7, 1996; First Author Santiago Munne, PhD
• 1997 - Selected as one of the “Best Doctors in the United States for Women” - Good Housekeeping Magazine, July 1997
• 1997 - Family Building Award, American Infertility Association
• 1998 - Best fellow paper. The Armed Forces District Meeting of the American College of Obstetrics and Gynecology, Orlando, Florida. First Author - Gregory S. Neal, MD

Professional appointments

• 1999-Present - Director, Assisted Reproduction Program Director, Embryology, Andrology and Endocrinology Laboratory, Reproductive Medicine Associates of New Jersey, Morristown, New Jersey 
• 1995- 1999 - Director, Assisted Reproduction Program, Clinical Director, Andrology and Endocrinology Laboratory, The Institute for Reproductive Medicine and Science of Saint Barnabas Medical Center Department of Obstetrics and Gynecology, St. Barnabas Medical Center, Livingston, New Jersey 
• 1999-2002 - Membership Committee, Society of Assisted Reproductive Technologists, American Society for Reproductive Medicine
• 1996-2000 - Society Development Committee, American Society for Reproductive Medicine
• 1999-Present - National Board of Directors, American Infertility Association

Original peer reviewed publications

1. Hankins GDV, Berryman GR, Scott RT, Hood D. Maternal arterial oxygen desaturation with treatment of uterine atony with 15-methyl prostaglandin F2 alpha. Obstet Gynecol 1988; 72:367
2. Kreiner D, Droesch K, Navot D, Scott R, Rosenwaks Z. Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstet Gynecol 1988; 72:926
3. Scott RT, Snyder RR, Strickland DM, Tyburski CC, Bagnall JA, Reed KR, Adair CA, Hensley SB. The effect of interobserver variation in dating endometrial histology in the diagnosis of luteal phase defects. Fertil Steril 1988; 50:888
4. Droesch KW, Navot D, Scott RT, Kreiner DK, Liu HC, Rosenwaks Z. Transdermal estrogen replacement in ovarian failure for ovum donation. Fertil Steril 1988; 50:931
5. Acosta AA, Oehninger SC, Morshedi M, Swanson RJ, Scott RT, Irianni F. Assisted reproduction in the diagnosis and treatment of the male factor. Obstet Gynecol Surv 1989; 44:1
6. Scott RT, Rosenwaks Z. Ovulation induction for assisted reproduction. J Reprod Med 1989; 34:42
7. Navot DM, Anderson TL, Droesch KD, Scott RT, Kreiner DK, Rosenwaks Z. Hormonal manipulation of endometrial manipulation. J Clin Endocr Metab 1989; 68:801
8. Oehninger SC, Scott RT, Muasher SJ, Acosta AA, Jones HW, Rosenwaks Z. Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transfer. Fertil Steril 1989; 51:126
9. Scott RT, Strickland DM, Hankins GDV, Gilstrap LC. Maternal height and weight gain as risk factors for cesarean section. Military Medicine 1989; 154:365
10. Scott RT, Hofmann GE, Muasher SJ, Acosta AA, Kreiner DK, Rosenwaks Z. A prospective randomized comparison of single and double lumen needles for transvaginal follicular aspiration. J In Vitro Fert Embryo Transfer 1989; 6:98
11. Oehninger SC, Coddington CC, Scott RT, Franken D, Acosta AA, Hodgen GD. Validation of the hemizona assay (HZA) in a monkey model: Influence of oocyte maturational stages. Fertil Steril 1989; 51:881
12. Oehninger SC, Coddington CC, Scott RT, Franken D, Acosta AA, Hodgen GD. Hemizona assay (HZA): Assessment of sperm dysfunction and prediction of in vitro fertilization (IVF) outcome. Fertil Steril 1989; 51:665
13. Scott RT, Toner JF, Muasher SJ, Oehninger SC, Robinson S, Rosenwaks Z. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989; 51:651
14. Scott RT, Hofmann GE, Muasher SJ, Acosta AA, Kreiner DK, Rosenwaks Z. Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal aspiration. J In Vitro Fertil Embryo Transfer 1989; 6:73
15. Scott RT, Oehninger SC, Menkveld R, Veeck LL, Acosta AA. Critical assessment of sperm morphology before and after double swim-up preparation for in vitro fertilization. Arch Androl 1989; 23:125
16. Archer DF, Hofmann GE, Brzyski R, Ross B, Scott RT, Philput CB, Oehninger SC, Ware JC. Effects of clomiphene citrate on episodic luteinizing hormone secretion throughout the menstrual cycle. Amer J Ob Gyn 1989; 161:581
17. Hofmann GE, Denis AC, Scott RT, Muasher S. The incidence of hyperprolactinemia in gonadotropin stimulated cycles for in vitro fertilization and its effect on cycle quality and pregnancy outcome. Fertil Steril 1989; 52:622
18. Karande VC, Scott RT, Jones GS, Muasher SSJ. Non-functional cysts do not affect ipsilateral or contralateral ovarian performance during in-vitro fertilization. Human Reprod 1990; 5:431
19. Scott RT, Hofmann GE, Oehninger SC, Muasher SJ, Rosenwaks Z. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990; 54:297
20. Hofmann GE, Scott RT, Brzyski RB, Jones HW, Jr.. Immunoreactive epidermal growth factor concentrations in follicular fluid obtained from in vitro fertilization. Fertil Steril 1990; 54:303
21. Karande VC, Scott RT, Archer DF. The relationship between serum estradiol-17ß concentrations and induced pituitary luteinizing hormone (LH) surges in post-menopausal women. Fertil Steril 1990; 54:217
22. Brzyski RG, Hofmann GE, Scott RT, Jones HW. Effects of leuprolide acetate on follicular fluid hormone composition at oocyte retrieval for in vitro fertilization. Fertil Steril 1990; 54:842
23. Hankins GDV, Lowery CL, Scott RT, Morrow WR, Carey KD, Leland MM, Colvin EV. Transplacental transfer of zidovudine (AZT) in the near term pregnant baboon. Amer J Obstet Gynecol 1990; 163:728-32
24. Scott RT. Response to the editor. J In Vitro Fertil Embryo Transfer 1989; 6:323
25. Karande VC, Scott RT, Archer DF. Pituitary luteinizing hormone (LH) secretion: Effect of different concentrations of serum 17ß-estradiol in postmenopausal women. Ann NYAS 592:405-8, 1990
26. Scott RT, Karande VC, Archer DF. Acute Changes in serum estradiol concentrations do no elicit changes in serum osteocalcin concentrations. Ann NYAS 592:472-3, 1990
27. Scott RT, Ross B, Anderson C, Archer DF. Pharmacokinetics of percutaneous estradiol: A crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 1991; 77:758-64
28. Scott RT, Hofmann GE, Veeck LL, Jones HW, Muasher SJ. Embryo quality and pregnancy rates in patients attempting pregnancy through in vitro fertilization. Fertil Steril 1991; 55:426-28
29. Navot D, Scott RT, Droesch K, Veeck LL, Liu H-C, Rosenwaks Z. The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril 1991; 55:114
30. Hofmann GE, Scott RT, Bergh PA, Delegdisch L. Immunohistochemical localization of epidermal growth factor (EGF) in human endometrium, decidua and placenta. J Clin Endocrinol Metab 1991; 73:882-87
31. Scott RT, Navot DM, Rosenwaks Z. A human in vivo model for the luteo-placental shift. Fertil Steril 1991; 56:481
32. Hofmann GE, Scott RT, Rosenwaks Z. Common errors in hysterosalpingography. Intl J of Fertility 1992; 37:41-3
33. Hofmann GE, Scott RT, Bergh PA, Delegdisch L. Immunohistochemical localization of epidermal growth factor (EGF) in human endometrium, decidua and placenta. J Clin Endocrinol Metab 1991; 73:882-87
34. Horowitz GM, Scott RT, Hankins GDV. Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population. J Reprod Med 1991; 36:773
35. Hofmann GE, Drews MR, Scott RT, Navot D, Heller D, Delegdisch L. Epidermal growth factor and its receptor in human implantation trophoblast: immunohistochemical evidence for autocrine/paracrine function. J Clin Endocrinol Metab 1992; 74:981-8
36. Satin AJ, Hankins GDV, Patterson WR, Scott RT. Creatine kinase as a marker for preterm labor. Am J Perinatology 1992; 9:456-59
37. Scott RT, Illions EH, Hayslip. Establishment of An Assisted Reproduction Program in the Armed Forces. Military Medicine 1993; 158:92-6
38. Hofmann GE, Horowitz GM, Scott RT, Navot D. Transforming growth factor-_ in human implantation trophoblast: Immunohistochemical evidence for autocrine/paracrine function. J Clin Endocrinol Metab 1993; 76:781-5
39. Horowitz GM, Scott RT, Drews MR, Navot D, Hofmann GE. Immunohistochemical localization of transforming growth factor-_ in human endometrium, decidua, and trophoblast. J Clin Endocrinol Metab 1993; 76:786-92
40. Scott RT, Carey D, Leland M, Navot D. Gonadotropin responsiveness to ultra low dose leuprolide acetate administration in baboons. Fertil Steril 1993; 59:1124-28
41. Scott RT, Illions EH, Hayslip CA. Letter to the Editor regarding "Establishment of An Assisted Reproduction Program in the Armed Forces" Military Medicine 1993; 158:A5
42. Scott RT, Dellinger CL, Leonardi MR, Illions EH, Hofmann GE, Navot D. Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test. Fertil Steril 1993; 60:242-6
43. Scott RT, Neal GS, Illions EH, Hayslip CA, Hofmann GE. The duration of leuprolide acetate administration prior to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins. Fertil Steril 1993; 60:247-53
44. Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 1993; 82:539-45
45. Scott RT, Snyder RR, Bagnall JW, Reed KD, Adair CF, Hensley SD. Evaluation of the impact of intra-observer variability on endometrial dating and the diagnosis of luteal phase defects. Fertil Steril 1993; 60:652-7
46. Navot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott RT, Garrisi GJ, Hofmann GE. Age related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril 1994; 61:97-101
47. Lanzendorf SE, Oehninger S, Scott R, Whitelock SR, Hodgen GD. Penetration of human spermatozoa through the zona pellucida of non-viable human oocytes. J Soc Gynecol Invest 1994; 1:69-73
48. Selick CE, Horowitz GM, Gratch M, Scott RT, Navot D, Hofmann GE. Immunohistochemical localization of transforming growth factor-$ in human implantation sites. J Clin Endocrinol Metab 1994; 78:592-6
49. Scott RT, Navot D. Enhancement of ovarian responsiveness with micro-doses of GnRH-agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994; 61:880-5
50. Scott RT, Bailey SA, Kost ER, Neal GS, Illions EH. Comparison of leuprolide acetate and hCG for the induction of ovulation in clomiphene citrate stimulated cycles. Fertil Steril 1994; 61:872-9
51. Woodruff JD, Pickar JH, and the Menopause Study Group. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 1994; 170:1213-23
52. Archer DF, Pickar JH, Bottiglioni F, and the Menopause Study Group. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol 1994; 83:686-92
53. Sharara FI, Beatse SN, Leonardi MR, Navot D, Scott RT. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test (CCCT) Fertil Steril 1994; 62:257-262
54. Scott RT, Illions EH, Carey KD, Navot D. Gonadotropin releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress circulating immunoassayable gonadotropin levels. Fertil Steril 1994; 62:1069-71
55. Sharara FI, Beatse SN, Bailey SA, Neal GK, Coddington CC, Scott RT. Tru-trax in vitro cervical mucus penetration testing. Human Reprod 1994; 9:2027-31 
56. Scott RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995; 63:1-11
57. Scott RT, Beatse SN, Illions EH, Snyder RR. Use of the GnRH-agonist stimulation test in the diagnosis of ovarian remnant syndrome. J Reprod Med 1995; 40:143-6
58. Gordon K, Scott RT, Williams RF, Danforth DR, Loozen HJJ, Kloosterboer HJ, Hodgen GD. In vivo effects of potent GnRH antagonist ORG 30850; Physiologic evidence that down-regulation of GnRH receptors does not occur. J Soc Gynecol Invest 1994; 1:290-6
59. Hofmann GE, Scott RT Jr, Horowitz GM, Thie J, Navot D. Evaluation of the reproductive performance of women with elevated day 10 progesterone levels during ovarian reserve screening. Fertil Steril 1995; 63:979-83
60. Copperman AB, Horowitz GM, Kaplan P, Scott RT, Navot D, Hofmann GE. Relationship between circulating hCG levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil Steril 1995; 63:1267-71
61. Sharara FI, Scott RT Jr. Measures of Association - Smoking and Fecundity. Fertil Steril 1995; 1350-1
62. Scott RT, Hofmann GE. Response to the Letter to the Editor "Screening for Ovarian Reserve". Fertil Steril 1995; 64:222-3
63. Scott RT, Opsahl MS, Leonardi MR, Neal GS, Illions EH, Navot D. Life table analysis of cumulative pregnancy rates based on the results of ovarian reserve screening and patient age in a general infertility population. Hum Reprod 1995; 7:1706-10
64. Sharara FI, Illions EH, Coddington CC, Scott RT. Tru-Trax in vitro cervical mucus penetration test in predicting fertilization and pregnancy rates in in vitro fertilization. Human Reprod 1995; 10:1481-5
65. Illions EH, Scott RT, Carey KD, Navot D. Differential down regulation of gonadotrope responsiveness following pulsatile GnRH-agonist administration in the presence and absence of long term GnRH-antagonist therapy. Fertil Steril 1995; 64:848-54
66. Scott RT, Hofmann GE. Not all assays are equal. Response to Letters-to-the-Editor. Fertil Steril 1996; 65:892
67. Hofmann, GE, Santilli, BA, Kindig S, Scott RT Jr, Johnson CA. Intraobserver, interobserver variation of sperm critical morphology: comparison of examiner and computer-assisted analysis. Fertil Steril 1996; 65:1021-5
68. Sharara FI, Scott RT Jr, Marut EL, Queenan JT. In vitro fertilization outcome in women with hydrosalpinx. Hum Reprod 1996; 11:526-30
69. Hofmann GE, Sosnowski, Scott RT Jr, Thie J. Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil Steril 1996; 66:49-53
70. Hofmann GE, Thie J, Scott RT Jr, Navot D. Endometrial thickness is predictive of histologic endometrial maturation in women undergoing hormone replacement for ovum donation. Fertil Steril 1996; 66:380-4
71. Opsahl M, Fritz M, Scott RT. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 1996; 66:533-7
72. Hofmann GE, Khoury J, Johnson CA, Thie J, Scott RT. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact in pregnancy outcome. Fertil Steril 1996; 66:980-6
73. Hofmann GE, Scott RT. Reply to the letter to the editor. How much is left in the tank - can we tell? Fertil Steril 1996; 66:1044
74. Denis AL, Guido M, Adler RD, Bergh PA, Brenner C, Scott RT Jr. Antiphospholipid antibodies and pregnancy rates and outcome in IVF patients. Fertil Steril 1997; 67:1084-90
75. Cohen J, Garrisi GJ, Congedo-Ferrara TA, Kieck KA, Schimmel TW, Scott RT. Cryopreservation of single human spermatozoa. Hum Reprod 1997; 12:994-1001
76. Cohen J, Scott R, Schimmel T, Levron J, Willadsen S. Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs. Lancet 1997; 350:186-8
77. Brenner C, Scott R, Cohen J. Use of anucleate donor oocyte cytoplasm in recipient eggs. Lancet 1997 350:961-3
78. Denis AL, Adler R, Scott RT Jr. A negative study with power. Response to Letters to the Editor, Fertil Steril 1998; 69:166-8
79. Sharara FI, Scott RT Jr, Seifer DB. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 1998; 179:804-12
80. Munne S, Morrison L, Fung J, Marquez C, Weier U, Bahce M, Sable D, Grunfeld L, Schoolcraft B, Scott R, Cohen J. Spontaneous abortions are reduced after preconception diagnosis or translocations. J Assist Reprod Genet 1998;15:290-6
81. Munne S, Scott R, Sable D, Cohen J. First pregnancies after preconception diagnosis of translocations of maternal origin. Fertil Steril 1998;69:675-81 
82. Cohen J, Scott R, Alikani M, Schimmel T, Munne S, Levron J, Wu L, Brenner C, Warner C, Willadsen S. Ooplasmic transfer in mature human oocytes. Mol Hum Reprod 1998;4:269-80
83. Alikani M, Cohen H, Tomkin G, Garrisi GJ, Mack C, Scott RT. Human embryo fragmentation in vitro and its implications for pregnancy and implantation. Fertil Steril 1999; 71:836-42
84. Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT Jr. Increased prevalence of antithyroid antibodies in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999; 71:843-8
85. Munne S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L, Tucker M, Marquez C, Sable D, Ferraretti AP, Massey JB, Scott R. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Human Reprod 1999;14:2191-9
86. Willadsen S, Levron J, Munne S, Shimmel T, Marquez C, Scott R, Cohen J. Rapid visualization of metaphase chromosomes in single human blastomeres after fusion with in-vitro matured bovine eggs. Hum Reprod 1999;14:470-5
87. Kutteh WH, Schoolcraft WB, Scott RT Jr. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod 1999;14:2886-90
88. Seifer DB, Scott RT Jr, Bergh PA, Abrogast LK, Friedman CI, Mack CK, Danforth DR. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 1999;72:63-5
89. Kutteh Wh, Schoolcraft WB, Scott RT Jr. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod. 1999 Nov;14(11):2886-90
90. Leondires MP, Escalpes M, Segars JH, Scott RT Jr, Miller BT. Microdose follicular phase gonadotropin-releasing hormone agonist (GnRh-a) compared with luteal phase GnRh-a for ovarian stimulation at in vitro fertilization. Fertil Sterile. 1999 Dec;72(6):1018-23 
91. Leondires MP, Ernst SD, Miller BT, Scott RT Jr. Triplets: outcomes of expectant management versus multifetal reduction for 127 pregnancies. Am J Obstet Gynecol. 2000 Aug;183(2):454-9
92. Frattarelli JL, Lauria-Costab DF, Miller BT, Bergh PA, Scott RT. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril 2000 Sep;74(3):512-7
93. Frattarelli JL, Bergh PA, Drews MR, Sharara FI, Scott RT. Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril 2000 Sep;74(3):518-24
94. Levi AJ, Drews MR, Bergh PA, Miller BT, Scott RT Jr. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil Steril 2001 Oct;76(4):670-4 
95. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT Jr. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001 Oct;76(4):666-9 
96. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT Jr, Schoolcraft W, Shapiro DB. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001 Jan;75(1):38-45
97. Scott RT Jr, Levi A. An experimental bagatelle or a wrong mistake? Reply of the authors. Fertil Steril. 2002; 78: 435-6
98. Miller KA, Elkind-Hirsch K, Benson M, Bergh P, Drews M, Scott RT. A new follicle aspiration set is equally effective and as well tolerated as the standard needle when used in a prospective randomized trial in a large in vitro fertilization program. Fertil Steril 2003; 81:191-3
99. Pang S, Kaplan B, Karande V, Westphal LM, Scott R, Givens C, Sacks P, Follistim Pen Trade Mark COH Study Group. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation. Reprod Biomed Online 2003; 7:319-26
100. Miller KA, Elkind-Hirsch K, Levy B, Grauber MD, Ross SJ, Scott RT Jr. Pregnancy after cryopreservation of donor oocytes and preimplantation genetic diagnosis of embryos in a patient with premature ovarian failure. Fertil Steril 2004; 82:211-4
101. Styne A, Elkind-Hirsch K, Scott RT. Value of basal FSH concentrations: prognostic implications for pregnancy outcome. Human Reprod 2004; 19:2426-7

Invited contributions

1.  Coddington CC, Scott RT. Prolactin: Physiology and pathophysiology. Medical Bulletin of the US Army Europe 1989; 4:32
2. Scott RT, Coddington CC. Amenorrhea - Diagnosis and Evaluation. Medical Bulletin of the US Army Europe 1989; 4:98
3. Gordon K, Scott RT, Williams RF, Danforth DR, Loozen SHG, Kloosterboer HJ, Hodgen GD. The hypothalamic-pituitary unit in chronic hyperandrogenism: Potential for management by development of a GnRH antagonist (ORG 30850). In: Proceedings of the Organon Round Table Conference. October 9-10, 1989, p 35.
4. Scott RT, Rosenwaks Z. Oocyte Donation - State of the art 1989. In: Advances in Assisted Reproductive Technologies. Edited by S Mashiach, Z Ben-Rafael, N Laufer and J Schenker. New York, Plenum Press, 1990, pp 633-642
5. Scott RT, Hodgen GD. The ovarian follicle: Life cycle of a pelvic clock. Clin Obstet Gynecol 1990; 33 (3):551
6. Hodgen GD, Kenigsberg D, Chillik C, Danforth Douglas, Leal J, Gordon, Scott R, Williams R. GnRH antagonists: New developments for indications in reproductive medicine. In: Advances in Assisted Reproductive Technologies. Edited by S Mashiach, Z Ben-Rafael, N Laufer and J Schenker. New York, Plenum Press, 1990, pp 213-220
7. Oehninger S, Scott R, Muasher SJ, Coddington CC, Acosta AA, Hodgen GD. Hemizona assay: Assessment of human spermatozoa dysfunction and its correlation with in vitro fertilization results. In: Advances in Assisted Reproductive Technologies. Edited by S Mashiach, Z Ben-Rafael, N Laufer and J Schenker. New York, Plenum Press, 1990, pp 515-524
8. Drew MR, Scott RT, Hofmann GE. Primary amenorrhea. Adol Ped Gynecol 1990; 4:119-28
9. Illions EH, Scott RT. Endometrial Ablation, San Antonio MD 1992; 2:6-7
10. Scott RT, Dellinger CL, Leonardi MR, Illions EH, Hofmann GE, Navot D. Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test. Fertility News 1994; 3:19-21
11. Johnson CA, Hofmann GE, Scott RT. The use of oil overlay for in vitro fertilization and culture. Assisted Reprod Rev 1994; 4:198-201
12. Toner JA, Scott RT. Prognostic assessment of ovarian reserve. Seminars in Reprod Endocrinol 1995; 1-14
13. Navot D, Bergh PA, Hofmann GE, Drews M, Garrisi JG, Scott RT. The embryo, the endometrium and the patient. in Perspectives on Assisted Reproduction; eds T Mori, T Tominaga, T. Aono, M. Hiroi. Ares-Serono Symposia Publications; Boston, MA, 1994, pp 347-52
14. Hofmann GE, Scott RT. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and their common (EGF) receptor. Potential relevance of this growth factor receptor system in normal human endometrium. Semin in Reprod Endocrin 1995; 13:109-19
15. Hofmann GE, Scott RT Jr, Horowitz GM, Thie J, Navot D. Evaluation of the reproductive performance of women with elevated day 10 progesterone levels during ovarian reserve screening. Ob/Gyn Digest 1995; November 27-29. Invited Abstract of Manuscript published in Fertility and Sterility
16. Scott RT. Evaluation and treatment of low responders. Semin in Reprod Endocrinol 1996; 14:317-338
17. Cohen J, Reing A, Garrisi GJ, Bar-Chama N, Scott R. Pregnancy after recovery of five testicular sperm cell cryopreserved under empty zona pellucida. In In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy. 1997; pp 105-10
18. Scott RT Jr, Bergh PA, Sable DB, Robins, ED, Miller BT, and Cohen J. Evaluation of the prognostic significance of day 3 FSH:LH ratios in in vitro fertilization. In In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy. 1997; pp 343-348
19. Brenner C, Exley G, Alikani M, Cohen J, Scott R, Adler R, Warner C. Expression of bax mRNA associated with apoptosis in human oocytes and embryos. In In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy. 1997; pp 627-32
20. Scott RT Jr, Bergh PA, Sable DB, Drews MR, Robins ED, Sharara F, Cohen J. Evaluation of the prognostic significance of day 3 E2 levels in in vitro fertilization. In In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy. 1997; pp 881-6
21. Scott RT JR, Denis AL, Guido M, Adler RD, Sable DB, Drews MR, Robins ED, Brenner C. Antiphospholipid antibodies and pregnancy rates and outcome in IVF patients. . In In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy. 1997; pp 855-60
22. Scott RT. Clinical markers of gametogenic failure. In Perimenopause. Ed by Rogerio A. Lobo, Serono Symposia, 1997; pp 119-143
23. Sharara FI, Scott RT. Ovarian reserve screening. Infert Reprod Med Clin NA 1997; 8:501-522
24. Scott RT, Silverberg K. Ethics of guaranteeing patient outcomes: a complex issue whose time has not come. Fertil Steril 1998; 70:424-4
25. Warner CM, Cao W, Exley GE, McElhinny AS, Alikani M, Cohen J, Scott RT, Brenner CA. Genetic regulation of egg and embryo survival. Hum Reprod 1998;13 Suppl 3:179-90; discussion 191-6
26. Hill JA, Scott RT. Immunologic tests and IVF: “Please, enough already”. Fertil Steril. 2000 74:439-42
27. Scott RT Jr. Déjà vu all over again. Fertil Sterile. 2000; 74:639-40
28. Scott RT Jr Diminished ovarian reserve and access to care. Fertil Steril 2004; 81:1478-85
29. Sharara FI, Scott RT. Assessment of ovarian reserve. Is there still a role for ovarian biopsy? First do no harm! Hum Reprod 2004; 19:470-1
30. Kaufmann RA, Gocial B, Crain JL, Webster BW, Scott RT, Miller PB, Elkind-Hirsch K, Scobey MJ. Bravelle, a New Highly Purified, Human-Derived FSH is Effective and Well Tolerated in Females Participating as Oocyte Donors for In Vitro Fertilization. Today’s Therapeutic Trends 2003; 21:1-14

Chapters in books

1. Kruger TF, Menkveld R, Scott RT, Jeyendran RS, Zaneveld LJD, Windt ML. Spermatozoa motile fraction separation. In Human Spermatozoa in Assisted Reproduction, eds Acosta AA, Swanson RJ, Ackerman SB, Kruger TF, van Zyl JA, Menkveld R. Williams & Williams, 1990, p 181
2. Mahony MC, Morshedi M, Scott RT, De Villiers A, Erasmus E. Role of spermatozoa cryopreservation in assisted reproduction. In Human Spermatozoa in Assisted Reproduction, eds Acosta AA, Swanson RJ, Ackerman SB, Kruger TF, van Zyl JA, Menkveld R. Williams & Wilkins, 1990, p 310
3. Scott RT, Rosenwaks A. Oocyte Donation. in Obstetrics and Gynecology, ed JJ Sciarra, JB Lippincott Co, Philadelphia PA, 5:100, 1990
4. Scott RT, Navot D. The assisted reproductive technologies in the treatment of male factor infertility. in Management of Impotence and Infertility, edited by ED Whitehead and HM Nagler, Williams and Wilkins, Baltimore, MD, 1994; pp 321-338 
5. Scott RT. Ultrasongoraphic evaluation of the endometrium during ovulation induction cycles. in Imaging in Infertility and Reproductive Endocrinology. R Jaffe, R Pierson, and J Abramowicz eds. JB Lippincott, Philadelphia PA. 1994; pp 53-62
6. Scott RT. Oocyte Donation in Obstetrics and Gynecology, ed JJ Sciarra, JB Lippincott Co, Philadelphia PA, 5:100, 1997
7. Scott RT. Oocyte Donation in Obstetrics and Gynecology, ed JJ Sciarra, JB Lippincott Co, Philadelphia PA, 5:100, 2002
8. Scott RT. Treatment of Low Responders in Textbook of Assisted Rerpoductive Techniques: Laboratory and Clinical Perspectives. Gardner DK, Weissman A, Howles C, Shoham Z. 1st edition. Taylor and Francis. 2001
9. Scott RT. Treatment of Low Responders in Textbook of Assisted Rerpoductive Techniques: Laboratory and Clinical Perspectives. Gardner DK, Weissman A, Howles C, Shoham Z. 2nd edition. Taylor and Francis. 2004

Published abstracts

1. Scott RT, Strickland DS, Hankins GDV, Hauth JC. Maternal height, weight, and weight gain as predictors of cesarean section risk. Presented at the 24th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, New Orleans, Louisiana, October 4-9, 1985
2. Scott RT, Bloss JD, Hankins GDV, Merwin M, Elrod JP, Snyder RR. Spectrophotometric determination of fetal hemorrhage. Presented at the 25th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Diego, California, October 5-10, 1986
3. Scott RT, Snyder RR, Strickland DM, Tyburski CC, Bagnall JA, Reed KR, Adair CA, Hensley SB. The effect of interobserver variation in dating endometrial histology in the diagnosis of luteal phase defects. Presented at the 26th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, Denver, Colorado, October 21-5, 1987
4. Scott R, Navot D, Droesch K, Kreiner D, Liu HC, Rosenwaks Z. A unique human model for studying early placental steroidogenesis and pregnancy maintenance. #420 Presented at the 35th Annual Meeting of the Society for Gynecologic Investigation, Baltimore, Maryland, March 17-20, 1988
5. Flood JT, Scott RT, Muasher SJ, Liu HC, Oehninger SC, Jones HW. Parameters for predicting the IVF outcome of women in their fifth decade. #72 Presented at the 70th Annual Meeting of The Endocrine Society, New Orleans, Louisiana, June 8-11, 1988
6. Scott RT, Strickland DS, Satin AJ, Wians F. The effects of commonly used hormonal replacement regimens on indices of lipid and bone metabolism. #713 Presented at the 70th Annual Meeting of the Endocrine Society, New Orleans, Louisiana, June 8-11, 1988
7. Oehninger S, Scott RT, Jones D, Acosta AA, Kreiner D. Effect of severity of tubo-ovarian disease and previous pelvic surgery on in vitro fertilization and embryo transfer (IVF-ET). P-033 Presented at the 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10-13, 1988
8. Droesch KD, Scott R, Kreiner D, Liu HC, Rosenwaks Z. Transdermal estrogen replacement therapy in ovarian failure for ovum donation. P-038 Presented at the 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10-13, 1988
9. Scott RT, Flood JT, Toner JP, Muasher SJ, Liu HC, Rosenwaks Z. Cycle day 3 follicle stimulating hormone levels are predictive of outcome in in vitro fertilization and embryo transfer. P-107. Presented at the 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10-13, 1988
10. Scott RT, Hofmann GE, Flood JT, Brzyski RG, Muasher SJ. Intercycle variability of Day 3 follicle stimulating hormone levels and its effect on stimulation quality in in vitro fertilization and embryo transfer (IVF/ET) P-236 Presented at the 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10-13, 1988
11. Scott RT, Droesch KW, Navot D, Rosenwaks Z. Efficiency of human conception in vitro related to the window of implantation. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
12. Scott RT, Hofmann GE, Acosta AA, Muasher SJ, Rosenwaks Z. A prospective randomized comparison of single and double lumen transvaginal follicular aspiration needles. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
13. Scott RT, Navot D, Droesch KW, Rosenwaks Z. A human in vivo model for the luteo-placental shift. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
14. Scott RT, Strickland DS, Satin AJ, Wians F. The effects of commonly used hormonal replacement regimens on indices of lipid metabolism. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
15. Scott RT, Strickland DS, Satin AJ, Wians F. The effect of postmenopausal hormone replacement therapy on indices of bone metabolism. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
16. Scott RT, Droesch KW, Navot KW, Rosenwaks Z. Cryopreservation in oocyte donation: Outcome and implications. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
17. Scott RT, Droesch KW, Navot D, Veeck LL, Rosenwaks Z. the effect of embryo quality on pregnancy rates in an oocyte donation program. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
18. Scott RT, Hofmann GE, Veeck LL, Muasher SJ, Rosenwaks Z. Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal follicular aspiration. Presented at the 27th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, San Antonio, Texas, November 6-10, 1988
19. Oehninger S, Scott RT, Coddington CC, Franken A, Acosta AA, Hodgen GD. Egg sperm interaction and validation of the hemizona assay (HZA) in a monkey model and influence of oocyte maturational stages. # 391 Presented at the 36th Annual Meeting of the Society for Gynecologic Investigation, San Diego, California, March 15-18, 1989
20. Denis ALC, Hofmann GE, Scott RT, Muasher SJ. The incidence of hyperprolactinemia during gonadotropin stimulation and its effect on ovulation in in vitro fertilization (IVF). # 398 Presented at the 36th Annual Meeting of the Society for Gynecologic Investigation, San Diego, California, March 15-18, 1989
21. Scott RT, Hofmann GE, Droesch KW, Rosenwaks Z. Cryopreservation has a markedly negative impact on pregnancy rates in ovum donation. # 455 Presented at the 36th Annual Meeting of the Society for Gynecologic Investigation, San Diego, California, March 15-18, 1989
22. Scott RT, Hofmann GE, Oehninger S, Muasher SJ, Jones GS, Jones HW JR. Progesterone concentrations and estradiol:progesterone ratios and endometrial receptivity. Presented at the VI World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April 2-7, 1989
23. Oehninger S, Scott RT, Coddington CC, Franken DR, Acosta AA. Evaluation of spermatozoa-binding ability to the zona pellucida (Hemizona Assay) in a monkey model and influence of oocyte maturational stages. Presented at the VI World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April 2-7, 1989
24. Oehninger S, Scott RT, Muasher SJ, Coddington CC, Acosta AA, Hodgen GD. Hemizona assay: Assessment of human spermatozoa dysfunction and its correlation with in vitro fertilization results. Presented at the VI World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April 2-7, 1989
25. Scott RT, Gordon K, Williams RF, Danforth DJ, Loozen HJJ, Kloosterboer HJ, Hodgen GD. New long acting GnRH-antagonist: Accelerated GnRH test response in primates. #216 Presented at the 71st Annual Meeting of The Endocrine Society, Seattle Washington, June 21-4, 1989
26. Scott RT, Hofmann GE, Muasher SJ, Liu HC, Rosenwaks Z. Intercycle variability of day 3 follicle stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Presented at the 28th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, Washington, D.C., November 5-9, 1989
27. Scott RT, Veeck LL, Jones HW Jr. Embryo quality is highly predictive of pregnancy rates in patients attempting pregnancy through in vitro fertilization. Presented at the 28th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, Washington, D.C., November 5-9, 1989
28. Scott RT, Gordon K, Williams RF, Danforth DR, Loozen HSG, Kloosterboer HJ, Hodgen GD. Accelerated GnRH induced secretory response in monkeys treated with a long GnRH-antagonist (Organon #30850). Presented at the 28th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, Washington, D.C., November 5-9, 1989
29. Scott RT, Hofmann GE, Oehninger S, Muasher SJ, Jones GES, Jones HW Jr. Progesterone concentrations and estradiol:progesterone ratios in the early and mid luteal phase effect endometrial receptivity. Presented at the 28th Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, Washington, D.C., November 5-9, 1989
30. Edelstein MC, Brzyski RG, Scott RT, Oehninger S, Simonetti S, Jones DL, Muasher SJ. Equivalency of human menopausal gonadotropins and pure follicle stimulating hormone for ovarian stimulation for in vitro fertilization after gonadotropin releasing hormone agonist suppression. O-090 Presented at the 45th Annual Meeting of the American Fertility Society, San Francisco, California, November 13-16, 1989
31. Hofmann GE, Brzyski RG, Scott RT, Jones HW Jr. Concentration of immunoreactive epidermal growth factor (iEGF) in follicular fluid obtained from in vitro fertilization (IVF): Correlation with gonadal steroid concentrations and oocyte quality in lupron and non lupron treated cycles. P-047 Presented at the 45th Annual Meeting of the American Fertility Society, San Francisco, California, November 13-16, 1989
32. Hofmann GE, Scott RT, Bergh PA, Coddington CC, Andersen T. Immunolocalization of gonadotropin releasing hormone like activity in human endometrium. Presented at the 37th Annual Meeting of the Society for Gynecologic Investigation, St Louis, Missouri, March 21-24, 1990
33. Hofmann GE, Scott RT, Jones HW Jr. Higher serum insulin like growth factor levels in women during a natural menstrual cycle compared to agonadal women on estrogen /progesterone replacement for ovum donation. O-108 Presented at the 46th Annual Meeting of the American Fertility Society, Washington D.C., October 15-18, 1990 
34. Drews MR, Scott RT, Heller D, Delegdisch L, Hofmann GE. Epidermal growth factor and its receptor in human implantation trophoblast: Immunohistochemical evidence for autocrine/paracrine function. Presented at the 38th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, Texas, March 20-23, 1991
35. Scott RT, Leonardi MR, Horowitz GM, Hofmann GE, Navot D. The value of the clomiphene citrate challenge test in a general infertility population. Presented at the 38th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, Texas, March 20-23, 1991
36.  Wagner BJ, Woodward PJ, Scott RT. Magnetic resonance imaging for Mullerian anomalies. Presentation at the Radiological Society of North America Meeting, Chicago, IL August 1991.
37. Coddington CC, Irianni F, Toth TL, Scott RT. Cervical mucus penetration testing with a Tru-Trax system is an excellent predictor of sperm mucus interaction in vivo after cervical insemination. Accepted for presentation at the Annual Meeting of the Andrology Society, Houston TX, October 1991
38. Scott RT. Establishment of an assisted reproduction program in the Armed Forces. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
39. Scott RT, Carey D, Leland M. Gonadotropin responsiveness to ultra low dose lupron administration in baboons. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
40. Leonardi MR, Mirabello J, Hofmann GE, Navot D, Scott RT. Value of clomiphene citrate challenge test screening in the general infertile population. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
41. Bailey SA, Kost ER, Yordan R, Romanoff M, Scott RT. Hypercarbia subcutaneous emphysema, pneumomediastinum, and pneumopericardium complicating operative laparoscopy. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
42. Bailey SA, Beatse SN, Kost ER, Neal GK, Coddington CC, Scott RT. Tru-Trax in vitro cervical mucus penetration (CMP) testing. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
43. Bailey SA, Scott RT. Depot leuprolide acetate induced ovulation with ensuing pregnancy. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
44. Bailey SA, Neal GK, Kost ER, Scott RT. Lupron for the induction of the mid-cycle LH-FSH surge. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
45. Kost ER, Schiano MA, Scott RT. Ovarian serous papillary cystadenofibroma of low malignant potential in a 20 year old female - a case report and literature review. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
46. Beatse SN, Satin AJ, Scott RT, Hankins GDV, Yeomans ER. The effect of epidural analgesia on the second stage of labor. Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
47. Dellinger CL, Leonardi MR, Bailey SA, Hofmann GE, Navot D, Scott RT. Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test (CCCT). Accepted for presentation at the American College of Obstetricians and Gynecologists, Armed Forces District Meeting, Cincinnati OH, November 4-8, 1991
48. Horowitz GM, Scott RT, Drew MR, Navot D, Grunfeld L, Hofmann GE. Immunohistochemical of Transforming Growth Factor-alpha in human Endometrium, Decidua and Trophoblast. Presented at the Society for Gynecologic Investigation, San Antonio, Texas, March 18-21, 1992
49. Scott RT, Carey D, Leland M, Navot D. Gonadotropin Responsiveness to Ultra-Low Dose Leuprolide Acetate Administration in Baboons. Presented at the Serono Symposia, Assisted Reproduction in Non-Human Primates, Beaverton, Oregon, May 28-31, 1992
50. Horowitz G, Scott RT, Drews MR, Hofmann GE. Immunohistochemical localization of transforming growth factor alpha in human implantation sites. P-298 Presented at the 45th Annual Meeting of the American Fertility Society, New Orleans, Louisiana, November 2-5, 1992
51. Lanzendorf SE, Oehninger S, Scott RT, Whitelock SR, Hodgen GD. Variables that influence the penetration of human sperm through the zona pellucida of human oocytes. S-54 Presented at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto Canada, March 31-April 3, 1993
52. Selick GE, Horowitz GM, Scott RT, Navot D, Hofmann GE. Immunohistochemical localization of transforming growth factor-beta in human implantation sites. P-323 Presented at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto Canada, March 31-April 3, 1993
53. Illions EH, Scott RT, Hofmann GE. A prospective, randomized, and cross controlled evaluation of the impact of oil versus open culture conditions in human in vitro fertilization. Presented at the Conjoint Meeting of the American Fertility Society and the Canadian Fertility and Andrological Society. October 9-14, 1993, P-029
54. Horowitz G, Scott RT, Drews MR, Hofmann GE. Immunohistochemical localization of transforming growth factor-alpha in human implantation sites. Presented at the Conjoint Meeting of the American Fertility Society and the Canadian Fertility and Andrological Society. October 9-14, 1993, P-298
55. Scott RT, Illions EH, Leland MM, Carey KD. Differential down regulation of gonadotrope responsiveness following pulsatile GnRH-agonist administration in the presence and absence of long term GnRH-antagonist therapy. Presented at the Armed Forces District Meeting of the American College of Obstetrics and Gynecology, Seattle Washington, October 31 - November 4, 1993
56. Scott RT, Illions EH, Carey KD, Leland MM. Evaluation of the age related changes in fecundity in the female baboon (papio cyanocephalus). Presented at the Armed Forces District Meeting of the American College of Obstetrics and Gynecology, Seattle Washington, October 31 - November 4, 1993
57. Opsahl MS, Cunningham DS, Robins ER, Scott RT, Fritz MA. Sonographic characteristics of endometrial and follicular development in serial clomiphene citrate-induced cycles. P-69, Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, Illinois, March 22-26, 1994
58. Johnson CA, Santilli BA, Scott RT, Kindig S, Hofmann GE. Intra- and inter-observer variation of sperm critical morphology comparison of examiner and computer assisted analysis. P-72, Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, Illinois, March 22-26, 1994
59. Scott RT, Illions EH, Carey KD, Navot D. Differential down regulation of gonadotrope responsiveness following pulsatile administration of GnRH-agonist (GnRH-a) administration in the presence and absence of long term GnRH-antagonist (GnRH-ant) therapy. P-46, Presented at the 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, Illinois, March 22-26, 1994
60. Copperman AB, Horowitz GM, Kaplan P, Scott RT, Navot D, Hofmann GE. Relationship between circulating hCG levels and premature luteinization in cycles of controlled ovarian hyperstimulation. The American Fertility Society. November 7-10, 1994, San Antonio, Texas; P-086
61. Hofmann GE, Scott RT, Horowitz GM, Thie J, Navot D. Correlation of day 10 progesterone during a clomiphene citrate challenge test (CCCT) as an indicator of a shortened follicular phase and correlation of P with CCCT parameters and clinical pregnancy outcome. The American Fertility Society. November 7-10, 1994, San Antonio, Texas; P – 088
62. Sharara FI, Illions EH, Coddington CC, Scott RT. Tru-Trax in vitro cervical mucus penetration testing correlates with fertilization rates in in vitro fertilization. The American Fertility Society. November 7-10, 1994, San Antonio, Texas; P – 107
63. Miller BT, Tichenor JR, Opsahl MS, Robins ED, Scott RT, Cunningham DS. Modulation of endometriosis-associated autoreactivity by peritoneal fluid components. The American Fertility Society. November 7-10, 1994, San Antonio, Texas; P – 138
64. Scott RT, Leonardi MR, Cunningham DS, Hofmann GE, Toner JP, Navot D. Serum LH levels during the clomiphene citrate challenge test are not predictive of miscarriage risk in the general infertility population. The American Fertility Society. November 7-10, 1994, San Antonio, Texas; P – 317
65. Miler BT, Kim T, Elevated FSH/LH ratios in women with normal ovarian reserve screening may be predictive of decreased pregnancy rates. The Armed Forces District Meeting of the American College of Obstetrics and Gynecology. San Diego, California. October 2-5, 1995
66. Hofmann GE, Johnson CA, Scott RT Jr. Sperm critical morphology does not predict pregnancy outcome in the general infertility population. The American Fertility Society. October 7-12, 1995, Seattle Washington, 0-097
67. Miller BT, Kim T, Hofmann GE, Navot D, Scott RT Jr. Elevated FSH/LH ratios in women with normal ovarian reserve screening may be predictive of decreased pregnancy rates. The American Fertility Society. October 7-12, 1995, Seattle Washington, P-114
68. Hofmann GE, Thie J, Scott RT Jr, Navot D. Endometrial thickness but not pattern determined by transvaginal ultrasonography is predictive of histologic evaluation of endometrial maturation in women undergoing hormone replacement for ovum donation. The American Society for Reproductive Medicine. October 7-12, 1995, Seattle Washington, P-151
69. Munne S, Scott R,. Bergh P, Cohen J. First pregnancies after polar body biopsy for testing of chromosome translocations. General Program Prize Paper. The American Society for Reproductive Medicine. November 2-6, 1996, Boston, Massachusetts, O-001
70. Blake M, Garrisi GJ, Sadowy S, Reing A, Tomkin G, Scott R, Cohen J. Sperm head and spindle position during intra-cytoplasmic sperm injection determine fertilization and development outcome. The American Society for Reproductive Medicine. November 2-6, 1996, Boston, Massachusetts, O-058
71. Scott RT, Bergh PA, Sable DB, Ernst SD, Ciggalione D, Jackson M, Raynault MF, Alikani M, Garrisi JA Ferrara TA, Drews MR. Unexplained implantation failure is much lower than previously reported. The American Society for Reproductive Medicine. November 2-6, 1996, Boston, Massachusetts, P-146
72. Cohen J, Reing A, Garrisi GJ, Bar-Chama N, Scott R. Pregnancy after recovery of five testicular sperm cell cryopreserved under empty zona pellucida. 10th World Congress on Inv Vitro Fertilization and Assisted Reproduction, Vancouver, BC, Canada May 24-28, 199; OC 13-111
73. Scott RT Jr, Bergh PA, Sable DB, Robins, ED, Miller BT, and Cohen J. Evaluation of the prognostic significance of day 3 FSH:LH ratios in in vitro fertilization. 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, BC, Canada May 24-28, 1997; PP 12-225
74. Munne S, Marquez C, Alikani M, Scott R, Cohen J. Chromosome abnormalities in embryos obtained after ICSI and regular IVF. 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, BC, Canada May 24-28, 1997; OC 21-187
75. Munne S, Sadowy S, Morton P, Tucker M, Magli C, Gianaroli L, Scott R, Grifo J, Cohen J. Over 100 cases of embryo biopsy and preimplantation genetic diagnosis of aneuploidy. 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, BC, Canada May 24-28, 1997; OC 22-196
76. Scott RT Jr, Bergh PA, Sable DB, Drews MR, Robins ED, Sharara F, Cohen J. Evaluation of the prognostic significance of day 3 E2 levels in in vitro fertilization. 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, BC, Canada May 24-28, 1997; PP 20-491
77. Scott RT JR, Denis AL, Guido M, Adler RD, Sable DB, Drews MR, Robins ED, Brenner C. Antiphospholipid antibodies and pregnancy rates and outcome in IVF patients. 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, BC, Canada May 24-28, 1997; PP 20-490
78. Brenner CA, Exley GE, Alikani M, Cohen J, McElhinny AS, Stachecki JJ, Scott RT, Warner CM. Apoptosis and Human Embryo Survival. Annual Meeting of the American Society for Reproductive Medicine, Cincinnati Ohio, October 18-22, 1997, O-174
79. Seifer DB, Scott RT, Bergh PA, Arbogast LK, Griedman CI, Mack CK, Danforth DR. Day 3 Serum Inhibin-B May be the Earliest Indication of Diminished Ovarian Reserve in Women Undergoing ART. Annual Meeting of the American Society for Reproductive Medicine, Cincinnati Ohio, October 18-22, 1997, O-184
80. Leondires MP, Miller BT, Escalpes M, Rogers BJ, Segars JH, Gehlbach DL, Scott RT. Clinical Efficacy and Cost Effectiveness of a Microdose GnRH-a Protocol Compared to a Luteal Phase GnRH-a Protocol for Controlled Ovarian Hyperstimulation. Annual Meeting of the American Society for Reproductive Medicine, Cincinnati Ohio, October 18-22, 1997, P-259
81. R.T. Scott Jr, R.R. Adler, K.Mack, R. Mack, T.J. Smith, C.A. Brenner, R. Walmsley, A. Reing, P.A. Bergh. Peripheral Natural Killer (NK) Cell Levels and Other Peripheral Lymphocyte Subsets (Reproductive Immunophenotype) Do Not Prognosticate IVF Implantation Rates, or Pregnancy Outcome. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; O-054
82. M. Raynault, N, Klugman, T.J. Smith, D. Costs, S. Munne, E.D. Robins Pregnancy Outcomes in Conceptions That Occur After Documentation of Abnormal Ovarian Reserve Screening. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; O-102
83. G.S. Neal, R.R. Adler, S.D. Ernst, T.J. Smith, M.M. Jackson, P.A. Bergh, R.T. Scott, Jr. Evaluation of the Predictive Value of Basal Serum Insulin-Like Growth Factor Binding Protein-3 Levels (IGF-BP3) for IVF Outcome. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; O-0200
84. M.P. Leondires, S.D. Ernst, B.T. Miller, R.T. Scott, Jr. Triplets: Outcomes of Multifetal Pregnancy Reduction (MFPR) versus Expectant management for 127 IVF Pregnancies, 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; O-210 
85. W.H. Kutteh, A.C. Carr, D.L. Yetman, R.T. Scott, Jr. Antithyroid Antibodies Do Not Effect Pregnancy Outcome in Women Undergoing Assisted Reproductive Technologies (ART). 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; O-310 
86. M.R. Drews, T.J. Smith, L.A. Morales, J. Qualter, R.T. Scott, Jr. Controlled Ovarian Hyperstimulation (COH) Has No Adverse Impact on Endometrial Receptivity. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; P-84
87. S.M. Bonamo, P.A. Bergh, R.T. Scott, Jr., G.J. Garrisi, M.J. Blake. Severe Male Infertility is Associated With Higher Early Pregnancy Loss Rate Compared to Couples With Normal Sperm Parameters. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; P-085
88. M.I. DeLuca, P.A. Bergh, R.T. Scott Jr., M. Alikani, S.A. Sadowy. High Quality Embryos Have High Implantation and Pregnancy Rates Regardless of the Quality of their Cohort. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; P-086
89. M. Dutkevich, M.E. Matthews, T.J. Smith, S.D. Ernst, M. Blake, M.R. Drews, R.T. Scott, Jr. Karotypic Abnormalities in Early Clinical Pregnancy Losses Among Infertile Women as Detected by Early Ultrasound Directed Chorionic Villus Sampling (CVS). 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; P-186
90. M.L. Slate, T.J. Smith, L.A. Morales, M.M. Jackson, E.D. Robins, R.T. Scott, Jr. Clinical Management of Cervical Heterotopic Pregnancies Following IVF With Maintenance of Viability of the Intrauterine Pregnancy. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 4-9,1998; P-188
91. Slate ML, Ernst SD, Jackson MM, Costa D, Smith TJ, Scott,RT. Evaluation of Implantation Rates in the Presence of Leiomyomata in Recipents of Donor Oocytes. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 27-30, 1999; 0-043
92. Jackson,M.M.,Slate,M.L.,Ernst,S.D.,Costa,D., Scott,R.T. Do Anonymous Donors Want to know the Outcome of the Cycle and Meet Any Offspring? 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada September 27-30, 1999; 0-044
93. Barritt,J.A., Cohen,J., Willadsen,S. Scott,R.T., Brenner,C.A. Mitochondrial Inheritance and the Incidence of Hereroplasmy After Ooplasmic Transplantation. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada September 27-30, 1999; 0-081
94. Frattarelli,J.L., Lauria-Costa,D.F., Miller,B.T., Scott Jr, R.T. Basal Antral Follicle Number and Ovarian Volume Predict Cycle Cancellation and Ovarian Responsiveness in In Vitro Fertilization. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 27-30, 1999; 0-14
95. Morris JL, Fratterelli, Dernst SD Smith T, Bergh PA, Scott RT Jr. Comparison of Follicle Stimulating Hormone Preparations: Results of Women Underoign GnRH-a Dwon Regulated IVF Cycles. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada September 27-30, 1999; P-206.
96. Madsen P, Scott RT, Fertility in society-quantitation and evaluation of perceptions about fertility and infertility within the general population. Presented at the 57th Annual Meeting of the American Society for Reproductive Medicine, Orlando, Florida, October 20-25, 2001
97. Meldrum D, Scott R, Levy M, Alper M, Noyes N, A pilot study to assess oral contraceptive (OC) pretreatment in women undergoing controlled ovarian hyperstimulation (COH) in ganirelix acetate cycles. Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 12-17, 2002
98. Miller K, Ross S, Levy B, Graubert M, Drews M, Scott RT, Pregnancy following oocyte cryopreservation with preimplantation genetic diagnosis (PGD) of the embryos. A case report. Presented at the 59th Annual Meeting of the American Society for Reproductive Medicine, San Antonio, Texas, October 11-15, 2003

Other publications

1. Scott RT. Ultrasound monitoring. in Ovarian Stimulation Monitoring: A roundtable review. ed by L. Bonaventura. 2nd in The Clinical Perspectives in Reproductive Endocrinology Series distributed by Serono Laboratories
2. Scott RT. Ultrasound monitoring of Controlled Ovarian Hyperstimulation. (Poster). Sponsored and distributed by Serono Laboratories
3. Seifer DB, Scott RT, Buyalos RP. Infertility after age 35: Diagnostic strategies. Ob Gyn Management 1996; October 47-54
4. Seifer DB, Scott RT, Buyalos RP. Infertility after age 35: Diagnostic strategies. Ob Gyn Management 1996; November 55-61
5. Wolfe L, Miller B, Scott RT. ACOG Audio Updates. Pretreatment evaluation and screening for ART. November 1999

Invited lectures
Outside Hospitals and Universities

1. Osteoporosis and Estrogen Replacement Therapy. Obstetrics and Gynecology Grand Rounds. Christopher Newport Hospital, Newport News, Virginia, October 12, 1988
2. Atherogenesis. Obstetrics and Gynecology Grand Rounds, Norfolk General Hospital, Norfolk Virginia, January 17, 1989
3. GnRH analogues - expanding indications for new medications. 45th MedCom Annual Review Course - Bitburg, West Germany, February 12, 1989
4. Prevention of Atherogenesis with estrogen replacement therapy. 45th MedCom Annual Review Course - Bitburg, West Germany, February 12, 1989
5. Clinical Evaluation and Management of Osteopenia. 45th MedCom Annual Review Course - Bitburg, West Germany, February 12, 1989
6. The Assisted Reproductive Technologies. 45th MedCom Annual Review Course - Bitburg, West Germany, February 12, 1989
7. Enhance Gonadotrope Responsiveness to GnRH following GnRH-antagonist Therapy - Reproductive Endocrinology Rounds - Mount Sinai Medical Center, New York, New York, July 22, 1989
8. Infertility in Women over 40. Lifetime Medical Television. Recorded November 18, 1990. (Televised multiple times)
9. Ovulation Induction in Subhuman Primates. Reproductive Endocrinology Rounds. Mt. Sinai Medical Center, New York, New York, March 18, 1991
10. Long-term Injectable Steroid Contraceptives. Bergstrom AFB Continuing Medical Education Lecture, Austin, Texas, May 14, 1991
11. Osteoporosis: Contemporary Approaches to Prevention. Annual Meeting of The Association of Naval Physician Assistants, Corpus Christi Texas, August 8, 1991
12. Operative Endoscopy - New Treatment Options. Tinker AFB, Continuing Medical Education Lecture. Oklahoma City, Oklahoma, August 18, 1991
13. The Clomiphene Citrate Challenge Test. Texas Society of Assisted Reproductive Technologists. Austin Texas, August 21, 1991
14. Aging of the Neuroendocrine Portion of the Reproductive Axis, Reproductive Endocrinology Rounds, Mt. Sinai School of Medicine, New York, New York, March 17, 1992
15. Endometrial Ablation. Grand Rounds, Mt. Sinai School of Medicine, New York, New York, March 18, 1992
16. Aging of the Reproductive Axis. Reproductive Endocrinology Rounds. The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia, April 1, 1992
17. Assisted Reproductive Technologies, Grand Rounds, Tinker AFB Hospital, April 7, 1992
18. Endometriosis, Current Concepts and Therapies. Grand Rounds, Ft. Hood Medical Center, Killeen, Texas, April 13, 1992
19. Assisted Reproductive Technologies in the Armed Forces. Specialty Section Lecture, Society of Air Force Clinical Surgeons, April 14, 1992
20. The Assisted Reproductive Technologies in the Military. Lonestar Chapter Meeting of NAACOG. San Antonio, Texas, April 24, 1992
21. Aging, Reproduction, and the CCCT. Grand Rounds, The Jones Institute for Reproductive Medicine, Norfolk VA, April 30, 1992
22. Estrogen Replacement Therapy, Continuing Medical Education Lecture, Kelly AFB Clinic, San Antonio, Texas, May 12, 1992
23. The Ideal Clinical Coordinator, Annual Meeting of the Association of Clinical Pharmacologists, Miami, Florida, May 30, 1992
24. Pharmacodynamics and Pharmacokinetics of GnRH-analogues. San Antonio Society of Pharmacists. San Antonio, Texas, June 6, 1992
25. Osteoporosis and Estrogen Replacement Therapy. Grand Rounds, Bergstrom AFB Hospital, Austin, Texas, June 9, 1992
26. Evaluation of First Trimester Bleeding. Continuing Medical Education Lecture, Whiteman AFB, Knob Noster, Missouri, July 13, 1992
27. Selecting the Appropriate Assisted Reproductive Technology - Resolve of San Antonio, September 12, 1992
28. Atherogenesis and Hormone Replacement Therapy. Annual Meeting of The Association of Naval Physician Assistants, Corpus Christi Texas, November 3, 1992
29. Long Term Injectable Contraceptives. Continuing Medical Education Lectures, Laughlin AFB, Del Rio, Texas, November 5, 1992
30. Recent Advances in Ovulation Induction. Obstetrics and Gynecology Grand Rounds. University of South Alabama, Mobile Alabama, November 20, 1992
31. Update on oral contraceptives - Grand Rounds, Bergstrom AFB, Austin, Texas, April 20, 1993
32. Prognostic Assessment of Female Fecundity. Update on Clinical Management of Infertility, Bethesda Hospital, Cincinnati Ohio, May 15, 1993
33. History of Ovum Donation. Update on Clinical Management of Infertility, Bethesda, Hospital, Cincinnati Ohio, May 15, 1993
34. Practical Management of an Ovum Donation Program. Update on Clinical Management of Infertility, Bethesda, Hospital, Cincinnati Ohio, May 15, 1993
35. Postmenopausal estrogen replacement therapy - risks, benefits, and alternatives, Internal Medicine Grand Rounds, Ft. Benning Army Medical Center, Columbus, Georgia, - June 8, 1993
36. Osteoporosis - Diagnoses, management, and prevention. Grand Rounds, Pope AFB, North Carolina, June 9, 1993
37. Estrogen Replacement Therapy, Obstetrics and Gynecology Grand Rounds, Pennsylvania Hospital, Philadelphia, Pennsylvania, July 22, 1993
38. Contemporary monitoring during ovulation induction with exogenous gonadotropins - Roundtable Seminar, Boston, Massachusetts, July 23, 1993
39. Papio cyanocephalus as model for study the climacteric - Advisory council on animal models in the menopause, The National Institute of Aging, Bethesda, Maryland - August 28, 1993
40. Assisted Reproduction in the 1990's, Obstetrics and Gynecology Grand Rounds, Walter Reed Army Medical Center, September 23, 1993
41. Hormone replacement therapy - Controversies in contemporary clinical management. Internal Medicine Grand Rounds, Womack Army Medical Center - Ft Bragg North Carolina, September 28, 1993
42. Oral Contraception - clinical problems solving, Family Practice Grand Rounds, Scott AFB, East St. Louis, Illinois, September 28, 1993
43. Dysfunctional Uterine Bleeding - Medical and surgical management. Family Practice Review Seminar, Scott AFB, East St. Louis, Illinois, September 29, 1993
44. Hormone Replacement Therapy - Contemporary management, Scott AFB, East St. Louis, Illinois, September 30, 1993
45. Recent advances in the clinical application of GnRH-analogues - Obstetrics and Gynecology Grand Rounds, New York Medical College, Valhalla, New York - October 28, 1993
46. Assisted Reproductive Technologies - Recent advances in clinical practice. Plenary Session, Annual Meeting of the Armed Forces District of the American College of Obstetrics and Gynecology, Seattle Washington, October 31, 1993
47. Prognostic Assessment of Ovarian Reserve - Grand Rounds, Department of Obstetrics and Gynecology, University of Maryland, February 4, 1994
48. Contemporary Controversies in Ovulation Induction - 45th Medcom Annual European Review Course, Willingen, Germany, April 18-22, 1994
49. Endoscopic Adhesolysis and Tuboplasty - 45th Medcom Annual European Review Course, Willingen, Germany, April 18-22, 1994
50. Endoscopic Evaluation of Adnexal Masses - 45th Medcom Annual European Review Course, Willingen, Germany, April 18-22, 1994
51. GnRH and GnRH Analogues - Changing Concepts and New Clinical Applications. Grand Rounds, Albert Einstein School of Medicine, New York, New York, May 3, 1994
52. Contemporary Management of the Menopause - Grand Rounds, McPherson Clinic, Atlanta Georgia, May 11, 1994
53. Menopause - Clinical Controversies and Contemporary Management - 1994 Post graduate course, Westchester County Medical Society, New York, May 18, 1994
54. Ovulation Induction - Practical Approaches; 1994 Post graduate course, Westchester County Medical Society, New York, May 18, 1994
55. Moderator, Reproductive Endocrine Session, 1994 Post graduate course, Westchester County Medical Society, New York, May 18, 1994
56. Pathophysiology of the Climacteric - Grand Rounds, New York Medical College, Valhalla New York, May 19, 1994
57. Combined Use of GnRH-Agonists and GnRH-Antagonists for Ovulation Induction. Reproductive Endocrinology Rounds - University of Maryland, Baltimore, Maryland, May 20, 1994
58. Prognostic Assessment of Ovarian Reserve - Grand Rounds, University of Nebraska Medical Center, Omaha, Nebraska, June 15, 1994
59. Endometrial Proliferation and Bleeding - Plenary Session, Annual Meeting of the North American Menopause Society. Washington D.C., September 22, 1994
60. Androgens in Continuous Hormone Replacement Therapy - Round Table, North American Menopause Society, September 22, 1994
61. Steroid Contraception - Grand Rounds, Hamilton Medical Center, Dalton, Georgia, October 6, 1994
62. Future Application with GnRH Analogues; "GnRH Agonists and Oocyte Quality" Mini-symposia - 50th Annual Meeting of the American Fertility Society; San Antonio, Texas; November 7-10, 1994
63. Update on Assisted Reproductive Technologies; Obstetrics and Gynecology Grand Rounds; William Beaumont Army Medical Center; El Paso, Texas - February 16, 1995
64. Practice and Pitfalls in Ovulation Induction. Reproductive Endocrinology Rounds, William Beaumont Army Medical Center; El Paso, Texas - February 16, 1995
65. Contemporary Estrogen Replacement Therapy. Obstetrics and Gynecology Grand Rounds; Texas Tech University; El Paso Texas - February 16, 1995
66. Medical Implications of Post Menopausal Hormone Replacement Therapy. Internal Medicine Grand Rounds. William Beaumont Army Medical Center; El Paso, Texas - February 17, 1995
67. Contemporary Issues in Estrogen Replacement Therapy. Obstetrics and Gynecology Grand Rounds, Travis Air Force Base, Sacramento, California, March 2, 1995
68. Medical Implications of Post Menopausal Hormone Replacement Therapy. Internal Medicine Grand Rounds, Travis Air Force Base, Sacramento, California, March 3, 1995
69. Recurrent Pregnancy Loss. Obstetrics and Gynecology Grand Rounds. St. Claires Hospital, Denville, New Jersey, June 18, 1995
70. Assisted reproduction - A workshop on implantation I; Lessons from oocyte donation. Post graduate course on implantation. The American Fertility Society. Seattle, Washington, October 8, 1995
71. Assisted reproduction - A workshop on implantation II; Sonographic assessment of endometrial receptivity, lessons learned from selective assisted hatching, and evaluation of the impact of hydrosalpinges. Post graduate course on implantation. The American Fertility Society. Seattle, Washington, October 8, 1995
72. Diagnosis and management of low responders in assisted reproduction. Seminar and workshop at the American Fertility Society. Seattle, Washington, October 11, 1995
73. Contemporary management of dysfunctional uterine bleeding. Obstetrics and Gynecology Grand Rounds. St. Vincents Hospital, New York, New York - October 19, 1995
74. Update on GnRH analogues. Department of Obstetrics and Gynecology Grand Rounds. The University of Florida, Gainesville, Florida - November 17, 1995
75. Clinical Markers of Gametogenic Failure. Serono Symposia on the Perimenopause. West Palm Beach, Florida - November 18, 1995
76. GnRH agonists and antagonists - A look into changing practice patterns and a look into the future. Organon National Headquarters. West Orange, New Jersey, January 23, 1995
77. Screening for Diminished Ovarian Reserve - Past, Present, and Future. Reproductive Endocrinology Rounds, Brigham and Womens Hospital, Harvard University; January 30, 1996
78. Osteoporosis- Pathophysiology and Management. Grand Rounds - National Naval Medical Center, Bethesda, Maryland, February 1, 1996
79. What’s New in Assisted Reproduction? Grand Rounds - National Naval Medical Center, Bethesda, Maryland, February 1, 1996
80. Contemporary Issues in Oral Contraception. Grand Rounds - Floyd Medical Center, Rome, Georgia, March 13, 1996
81. Clinical Markers of Gametogenic Failure - Obstetrics and Gynecology Grand Rounds. New Jersey Shore Medical Center. Brick, New Jersey, April 18, 1996
82. Microdose GnRH-a for the Stimulation of Low Responders - Plenary Session, Texas ART Society, Austin Texas, June 1-2, 1996
83. Update on Oocyte Donation - Texas ART Society, Austin Texas, June 1-2, 1996
84. Molecular Markers of Implantation, State of the Art and a Look into the Future - Texas ART Society, Austin Texas, June 1-2, 1996
85. Reviewer, Resident Research Day, Portsmouth Naval Medical Center, June 21, 1996
86. Contemporary Management of Estrogen Replacement Therapy - Ob/Gyn Grand Rounds, Portsmouth Naval Medical Center, June 21, 1996
87. What’s New in the Assisted Reproductive Technologies - Plenary Session, Armed Forces District Meeting of the American College of Obstetrics and Gynecology. Nashville, Tennessee, October 21, 1996
88. Dysfunctional Uterine Bleeding - Physiology, Pathophysiology, and Contemporary Management. Plenary Session, Armed Forces District Meeting of the American College of Obstetrics and Gynecology. Nashville, Tennesse, October 21, 1996
89. Recent Advances in the Assisted Reproductive Technologies. Grand Rounds, University of Alabama in Tuscaloosa, Tuscaloosa Alabama, October 25, 1996
90. Histology of the Endometrium II: Pathophysiologic States. Course VI- Endometrial Molecules, Architecture, Imaging and Functioning Reproductive Medicine; Twenty-Ninth Annual Postgraduate Program, American Society for Reproductive Medicine, Boston Massachusetts, November 2, 1996
91. Endometrial Imaging - Sonography (Part I) and Other Modalities (Part II). Course VI- Endometrial Molecules, Architecture, Imaging and Functioning Reproductive Medicine; Twenty-Ninth Annual Postgraduate Program, American Society for Reproductive Medicine, Boston Massachusetts, November 2, 1996
92. Assisted Reproduction: A Workshop on Implantation; Lessons Learned from Oocyte Donation. Course VI- Endometrial Molecules, Architecture, Imaging and Functioning Reproductive Medicine; Twenty-Ninth Annual Postgraduate Program, American Society for Reproductive Medicine, Boston Massachusetts, November 3, 1996
93. Evaluation of the Impact of Hydrosalpinges and Endometriosis on Implantation. Course VI- Endometrial Molecules, Architecture, Imaging and Functioning Reproductive Medicine; Twenty-Ninth Annual Postgraduate Program, American Society for Reproductive Medicine, Boston Massachusetts, November 3, 1996
94. Clinical Markers of Ovarian Function. From Genotype to Phenotype: Fertility Across the Reproductive Life cycle. Phoenix, AZ, February 6, 1997
95. Ovulation Induction Regimens for High and Low Responders. From Genotype to Phenotype: Fertility Across the Reproductive Life cycle. Phoenix, AZ, February 7, 1997
96. Update on the Assisted Reproductive Technologies. Ob/Gyn Grand Rounds, University of Medicine and Dentistry of New Jersey - Camden. February 11, 1997
97. Ovulation Induction - Strategies and Pitfalls. Ob/Gyn Grand Rounds, Monmouth County Medical Center, February 20, 1997
98. Development of Infertility Therapy - Obstetrics and Gynecology Post Graduate Course,. Phoenix Arizona, April 7, 1997
99. Clinical Evaluation of Ovarian Reserve. Plenary Lecture at the Pacific Coast Fertility Society, Palm Springs California, April 11, 1997
100. Microdose Agonist Stimulations for In Vitro Fertilization - Roundtable at the Pacific Coast Fertility Society, Palm Springs California, April 13, 1997
101. What’s New in Stimulation of In Vitro Fertilization. Reproductive Endocrinology Rounds, UMDNJ Medical School, May 14, 1997
102. Where do IVF Failures Come From?- Obstetrics and Gynecology Grand Rounds, Holy Name Hospital, Teaneck, New Jersey, June 18, 1997
103. Recent Advances in ART - Dinner Seminar, Princeton, New Jersey, June 18, 1997
104. Principles of Ovulation Induction - Ob/Gyn Grand Rounds, Bethesda Hospital, Cincinnati, Ohio, July 24, 1997
105. Evaluation and Management of IVF Failures, Dinner Seminar Sponsored by Serono Laboratories, Cincinnati Ohio, July 24, 1997
106. Circulating Antiphospholipid Antibodies and IVF Outcome, South East Reproductive Medicine Associates (SERMA) Annual Meeting, Greenville, South Carolina, September 5, 1997
107. Results of Fertinex Stimulations for In Vitro Fertilization, South East Reproductive Medicine Associates (SERMA) Annual Meeting, Greenville, South Carolina, September 5, 1997
108. Protocol Strategies for IVF, Grand Rounds, North Shore University Hospital, Long Island, October 9, 1997
109. Strategies for Improving Outcomes in IVF, Texas Resolve, Austin Texas, October 11, 1997
110. Discussant, General Program Prize Paper, Annual Meeting of the American Society for Reproductive Medicine, Cincinnati Ohio, October 18-22, 1997
111. Diminished Ovarian Reserve Screening. Round Table, Annual Meeting of the American Society for Reproductive Medicine, Cincinnati Ohio, October 18-22, 1997
112. Strategies for Improving Outcomes in Older Women, Seminar and Workshop, Annual Meeting of the American Society for Reproductive Medicine, Cincinnati Ohio, October 18-22, 1997
113. Evaluation of Ovarian Reserve, Workshop on Ovarian Aging, November 13-15, 1997, Hoorvelaken, Netherlands
114. Evaluating Protocol Strategies for the Assisted Reproductive Technologies. Obstetrics and Gynecology Grand Rounds, Toledo Medical Center, Toledo Ohio, November 20, 1997
115. Surgical Correction of Mullerian Anomalies. General Surgery Grand Rounds, Saint Barnabas Medical Center, Livingston, New Jersey, January 14, 1997
116. Factors Influencing the Success Rates of the Assisted Reproductive Technologies, The Baltimore-Washington Reproductive Endocrine Society. February 26, 1998
117. Understanding Reproductive Senescence, Grand Rounds, Department of Obstetrics and Gynecology, Jefferson University Medical School, Philadelphia, Pennsylvania, March 14, 1998
118. Understanding IVF Failure; Grand Rounds, The Center for Human Reproduction, Chicago, Illinois; March 19, 1998
119. Understanding the Role of Cytoplasmic Transfer in Treating Infertility. Gyn-Cor National Annual Review Course, Chicago, Illinois, March 20, 1998
120. What is New with the Assisted Reproductive Technologies. Department of Obstetrics and Gynecology Grand Rounds, Jefferson Medical School, Philadelphia, Pennsylvania March 26, 1998
121. The Physiology and Pathophysiology of Implantation Failure in IVF. Dinner Presentation to Florida Society of Reproductive Endocrinologists. April 10, 1998
122. Osteoporosis. Grand Rounds, National Naval Medical Center, Bethesda Maryland. April 23, 1998
123. Cytoplasmic Donation. Plenary Session, Annual Meeting of the Florida Society of Reproductive Endocrinologists. April 11, 1998
124. Follicular Dynamics and the Physiology of Ovarian Stimulation for the ART’s. Serono Symposia, Advances in Reproductive Endocrinology and Infertility for Nurses; May 16, 1998
125. Prognostic Assessment of Ovarian Reserve. Serono Symposia, Advances in Reproductive Endocrinology and Infertility for Nurses; May 16, 1998
126. Contemporary Ovarian Reserve Screening. 11th Annual UCLA Assisted Reproduction Review Course. Santa Barbara California. July 19-22, 1998
127. Immunologic Screening for ART. 11th Annual UCLA Assisted Reproduction Review Course. Santa Barbara California. July 19-22, 1998
128. Assessment of Ovarian Reserve. Organon Review Course,. Orlando Florida, August 28, 1998
129. Cytoplasmic Transfer. Organon Review Course, Orlando, Florida, August 28, 1998
130. Patient selection for the Assisted Reproductive Technologies. The Nalle Clinic, Charlotte North Carolina
131. Cytoplasmic Transfer. Trilogy Lecture, 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 8,1998
132. Apoptosis in follicles and embryos human assisted reproductive technologies. 54th Annual Meeting of the American Society for Reproductive Medicine and 16th World Congress on Fertility and Sterility, San Francisco, California. October 8,1998
133. Selection of the number of embryos for transfer and the impact on multiple pregnancy rates in the Assisted Reproductive Technologies. Plenary Lecture, Armed Forces District Meeting of the American College of Obstetrics and Gynecology, Orlando, Florida, October 21, 1998
134. Understanding IVF Success and Failure. Pittsburgh Area Reproductive Endocrine Society. Pittsburgh PA, December 14, 1998
135. The Use and Abuse of Clomiphene Citrate. Grand Rounds, Department of Obstetrics and Gynecology, Allegheny University Hospital, Pittsburgh PA, December 15, 1998
136. Infertility and the Assisted Reproductive Technologies. Annual Meeting of the Chicago and Midwest Medical Societies. Chicago, Illinois, February 26, 1999
137. Understanding Reproductive Failure. Grand Rounds, Department of Obstetrics and Gynecology, Georgetown University, Washington DC, April 14, 1999
138. Understanding IVF Success and Failure. Plenary Lecture, Annual Meeting of the Pacific Coast Fertility Society, La Jolla, California, April 15-18, 1999
139. Update on Ovarian Reserve Screening. Annual Meeting of the Pacific Coast Fertility Society, La Jolla, California, April 15-18, 1999
140. Debate on Reproductive Immunology Screening in Infertility. - Con . Annual Meeting of the Pacific Coast Fertility Society, La Jolla, California, April 15-18, 1999
141. What’s New in Ovarian Reserve Screening. Grand Rounds, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia. May 5, 1999
142. Update in IVF. Jones Institute for Reproductive Medicine Divisional Rounds. Norfolk, Virginia, May 5, 1999
143. Rosden Memorial Lecture. Cytoplasmic Donation - Indications and Pifalls. Beth Isreal Medical Center, Harvard Medical School. Boston Massachusetts, May 23, 1999
144. Indications for Oocyte Donation. National Meeting on the “The ART of Donor Oocytes”. Charleston, South Carolina, May 30, 1999
145. The Role of Intracellular Therapy in ART. New York Reproductive Medicine Society. June 9, 1999.
146. What’s New in ART. The New Jersey Ob/Gyn Society. Atlantic City NJ. May 28, 1999
147. What is New in Infertility Care? National Meeting of the East Asian Medical Society, Atlantic City, New Jersey, July 8, 1999
148. The Role of Protocol Selection in Stimulation for the Assisted Reproductive Technologies. Ferring Pharmaceutical Advisory Group, Santa Barbara, California, July 17, 1999
149. Ovarian Reserve Screening - What are the Go- No Go Levels? 12th Annual UCLA Assisted Reproduction Review Course. Santa Barbara California. July 18-21, 1999
150. Immunology Screening and the Assisted Reproductive Technologies - What makes sense? 12th Annual UCLA Assisted Reproduction Review Course. Santa Barbara California. July 18-21, 1999
151. Understanding IVF Failures. Annual ART Nursing Meeting (Organon). Toronto, Canada. August 27, 1999
152. Blastocyst Transfer and Oocyte Donation. Annual ART Nursing Meeting (Organon). Toronto, Canada. August 27, 1999
153. Understanding IVF Success and Failure. Ferring sponsored symposia, Skydome, Toronto Canada, September 24, 1999
154. The Role of Immunologic Evaluation and Therapy in IVF. Reproductive Immunology Special Interest Group Annual Review Course. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 26, 1999
155. Cytoplasmic and Nuclear Transfer – New Life for an Old Egg? Society for Assisted Reprodutcive Technology Annual Review Course. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 25-26, 1999
156. Management of the Low Responders. Society for Assisted Reproductive Technology Annual Review Course. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 25-26, 1999
157. Testing and Predicting Ovarian Reserve. Society for Assisted Reproductive Technology Annual Review Course. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 25-26, 1999
158. Variations of Protocols for GnRH-antagonist Treated Cycles. Symposia on GnRH-antagonist. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 27, 1999
159. Understanding IVF Failures in the Treatment of Male Factor Infertility. Symposia on Male Factor Infertility. 55th Annual Meeting of the American Society for Reproductive Medicine and Canadian Fertility and Andrology Society. Toronto, Canada, September 28, 1999
160. Understanding IVF Success and Failure. Michigan Reproductive Endocrine Society Quarterly Meeting. Detroit, Michigan, Sept 28 , 1999
161. Grand Rounds, Department of Obstetrics and Gynecology, University of Michigan, September 29, 1999
162. Clinical Applications of Antagon. Launch Meeting for Antagon, Organon Pharmaceuticals, Tuscon, Arizona. September 30, 1999
163. Stimulation Strategies for Complex IVF Patients. Denver area Reproductive Endocrinologists. October 18, 1999
164. The Phyisology of IVF. Grand Rounds, Department of Obstetrics and Gynecology, Uniformed Services University, Bethesda, Maryland. October 20, 1999
165. Understanding IVF Success and Failure. Grand Rounds, Department of Obstetrics and Gynecology, Women and Infants Hospital, Brown University, Providence, Rhode Island, October 28, 1999
166. New Treatments in ART. Ferring Sponsored Dinner Program. Los Angeles California, November 16, 1999
167. New Strategies for IVF Success. San Diego Area Reproductive Endocrine Society. San Diego California, November 17, 1999
168. ART Pre-Treatment Strategies - OCPs and GnRH analogs. Serono Sponsored Symposia. Santa Monica, California. August 18-20, 2000 
169. Agonists vs. Antagonists: Clinical Application. “Smart Art: From Physiology to Clinical Success”. Medical Education Collaborative. Chicago, Illinois. August 24, 2000
170. Follicular Recruitment Implications for OI/IVF. “Smart Art: From Physiology to Clinical Success”. Medical Education Collaborative. Chicago, Illinois. August 24, 2000
171. GnRH Antagonists. Protocol Variations for Clinical Applications. FIGO Symposium. Washington, D.C. September 6, 2000
172. Ovarian Reserve and Fertility. Resolve Sponsored Symposium. New York, New York. September 17, 2000
173. Defining, Evaluating and Treating Reproductive Senescence. Regional Update In Infertility Management Conference. University of Rochester. Rochester, New York. September 23, 2000
174. “GnRH Antagonist - Protocols and Pitfalls”. South Jersey Reproductive Endocrinology Group. Voorhees, New Jersey. September 26, 2000
175.  “Stimulating the Difficult Patient”. Boston IVF. Waltham, Massachusetts. September 27, 2000
176. Understanding IVF Success and Failure. Philadelphia Area Reproductive Endocrine Society. Philadelphia, Pennsylvania. October 5, 2000
177. Physiology of GnRH Agonists and GnRH Antagonists. Reproductive Endocrine Conference. Bethesda Department of Medical Education. Cincinnati, Ohio. October 11, 2000
178. Post Graduate Course - “Appropriate Patient Evaluation Before ART”. 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 21, 2000
179. Post Graduate Course - Debate - “Resolved that Recombinant Gonadotropins Should be Used Instead of Human Menopausal Gonadotropins”. 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 21, 2000
180. Post Graduate Course - “The Role of Immunotherapy in ART”. 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 22, 2000
181. Post Graduate Course - Debate - “Resolved that ART Transfers Should be Limited to Two Embryos or One Blastocyst for all Women Less than Age 38". 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 22, 2000
182. “Immunologic Testing and Treatment in ART”. Roundtable. 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 23, 2000
183. Seminar and Workshop Lecture. “Immune Testing and Therapy for Reproductive Failure”. 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 24, 2000
184. RISG Workshop and Seminar. “Assessment of the Clinical Value of Immune Screening and Treatment in the General Infertility Population”. 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 24, 2000
185. Seminar and Workshop Lecture. “Debate: Can and Should ART Centers be Compared?” 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California. October 25, 2000
186. Ovum Donor Series. “Medical Overview”. The American Infertility Association. New York, New York. November 6, 2000
187. “Management of the Difficult Patient”. St. John’s Mercy Medical Center, Department of Obstetrics and Gynecology. St. Louis, Missouri. November 7, 2000
188. Management of Pregnancy with Immunologic Disorders concentrating on “worthfulness of IM therapy with Heparin, Steroids and IVIG”. Grand Rounds. St. John’s Mercy Medical Center, Department of Obstetrics and Gynecology. St. Louis, Missouri. November 8, 2000
189. “Polycystic Ovarian Disease and Insulin Resistance - New Approaches to Clinical Management”. Grand Rounds. Morristown Memorial Hospital, January 4, 2001
190. “Current Status of Human Oocyte Cryopreservation and Clinical Implications”. American Association of Bioanalysts. Biology of the Mammalian Oocyte: Influences on Human In Vitro Maturation and Cryopreservation. Miami Beach, Florida. March 3, 2001.
191.  “State of the ART in IVF”. Eighth Annual Update in Obstetrics and Gynecology. University of Pittsburgh School of Medicine. Vail, Colorado. March 11, 2001.
192. “Myths and Realities in Immune Screening in Infertile Women”. Eighth Annual Update in Obstetrics and Gynecology. University of Pittsburgh School of Medicine. Vail, Colorado. March 13, 2001.
193. “Ovarian Reserve Screening”. Eighth Annual Update in Obstetrics and Gynecology. University of Pittsburgh School of Medicine. Vail, Colorado. March 15, 2001.
194.  “Selection of Patients and Management of ART Cycles”. Serono Symposia. Frontiers in Reproductive Endocrinology. Washington, D.C. March 30, 2001.
195. “Immunologic Testing”. Serono Symposia. Frontiers in Reproductive Endocrinology. Washington, D.C. March 31, 2001.
196. “Use of Antagonists”. Serono Sponsored. Philadelphia, Pennsylvania. April 9, 2001.
197.  “Infertility Treatment and Multiple Pregnancy Rates - Problems and Solutions”. Grand Rounds. Overlook Hospital. April 25, 2001.
198. “Ovarian Reserve and Aging”. Post Graduate Course. Advances in Practical Endocrinology. ACOG Annual Meeting. Chicago, Illinois. April 28, 2001.
199.  “Immunology and Infertility”. Post Graduate Course. Advances in Practical Endocrinology. ACOG Annual Meeting. Chicago, Illinois. April 28, 2001.
200.  “When to go to IVF”. Post Graduate Course. Advances in Practical Endocrinology. ACOG Annual Meeting. Chicago, Illinois. April 29, 2001.
201. “GnRH Antagonists”. Post Graduate Course. Advances In Practical Endocrinology. ACOG Annual Meeting. Chicago, Illinois. April 29, 2001.
202. “Use of Antagonists”. Serono Sponsored Dinner. Washington University. St. Louis, Missouri. June 6, 2001
203. “GnRH Antagonists and IVF”. Serono Sponsored. Grand Rounds. Stanford University. Stanford, California. June 25, 2001.
204. “GnRH Antagonists and IVF”. Serono Sponsored. Dinner Program. San Francisco, California. June 25, 2001.
205. “GnRH Antagonists and IVF”. Serono Sponsored. Northern California Fertility Center. Sacramento, California. June 26, 2001. 
206. “Human Verses Recombinant Gonadotropins”. Ferring’s Scientific Advisory Board Meeting. Scottsdale, Arizona. March 8, 2002
207. “Role of Immunologic Testing”. University of California San Francisco Post Graduate Review Course. San Francisco, California. April 12, 2002.
208.  “Unexplained Infertility”. University of California San Francisco Post Graduate Review Course. San Francisco, California. April 12, 2002.
209. “GnRH Antagonists”. Pacific Coast Reproductive Society Annual Meeting. Rancho Mirage, California. April 18, 2002.
210. "Stimulation Protocols for Ovulation Induction and ART: The Role of Pre-Cycle Testing". Pacific Coast Reproductive Society Annual Meeting. Rancho Mirage, California. April 19, 2002. 
211. “Optimizing ART from Stimulation to Embryo Transfer”. Pacific Coast Reproductive Society Annual Meeting. Rancho Mirage, California. April 18, 2002.
212. “Ovarian Reserve”. Post Graduate Course; American College of Obstetrics and Gynecology Annual Clinical Meeting. Los Angeles, California. May 4, 2002.
213. “When To Go IVF”. Post Graduate Course; American College of Obstetrics and Gynecology Annual Clinical Meeting. Los Angeles, California. May 4, 2002.
214.  “Recurrent Pregnancy Loss”. Post Graduate Course; American College of Obstetrics and Gynecology Annual Clinical Meeting. Los Angeles, California. May 4, 2002.
215.  “Medications for Reproductive Endocrinology & Infertility – What’s New & What’s Next”. Post Graduate Course; American College of Obstetrics and Gynecology Annual Clinical Meeting. Los Angeles, California. May 4, 2002
216. “IVF Should be the First Line of Diagnosis and Treatment”. Workup of Infertility Session. The 3rd World Congress on Controversies in Obstetrics, Gynecology & Infertility. Washington, D.C. June 21, 2002. 
217. "Ovarian Reserve Testing and Stimulation of the Poor Responder". 15th Annual IVF and Embryo Transfer. Annual Review Course in IVF, UCLA School of Medicine. July 14, 2002.
218. "Immunologic Testing and Treatment Before IVF - Evidence Not Empiricism". 15th Annual IVF and Embryo Transfer. . Annual Review Course in IVF, UCLA School of Medicine. July 17, 2002.
219. "Assessment of Embryos". Smart Art III: From Physiology to Clinical Success. Las Vegas, Nevada. August 22, 2002.
220.  "Selecting the Optimal Protocol for the Patient Undergoing IVF: An Exchange of Ideas. American Society of Reproductive Medicine – Educational Symposium. October 14, 2002.
221. “Ovarian Reserve”. Grand Rounds, Jones Institute. Norfolk, Virginia October 25, 2002.
222. “Physiological Aspects of Ovarian Reserve”. Kansas City Gynecological Study Meeting. St. Luke’s Hospital. November 21, 2002.
223.  “GnRH Antagonists” Quarterly Meeting of the Greater Los Angeles Reproductive Endocrine Society. March 4, 2003
224. “Evaluation of Reproductive Potential and Ovulation Induction for ART Cycles” Serono Symposia, Savannah Georgia, March 11, 2003
225.  “Understanding Fundamental Human Clinical Embryology” Serono Symposia, Savannah Georgia, March 14, 2003
226. “Clinical Applicability of New Andrological Tests to Determine Male Reproductive Competence” Pacific Coast Reproductive Society – Annual Meeting. Rancho Mirage, California. April 22, 2003
227. “Infertility Evaluation and Treatment for the Generalist”. Post Graduate Course, Annual Meeting of the American College of Obstetricians and Gynecologists, New Orleans, Louisiana April 26, 2003
228.  “Ovarian Reserve Testing: Who, When, How, Why?” Post Graduate Course, Annual Meeting of the American College of Obstetricians and Gynecologists, New Orleans, Louisiana April 26, 2003
229.  “Recurrent Loss” Post Graduate Course, Annual Meeting of the American College of Obstetricians and Gynecologists, New Orleans, Louisiana April 27, 2003
230. “New Therapies in Infertility” Post Graduate Course, Annual Meeting of the American College of Obstetricians and Gynecologists, New Orleans, Louisiana April 27, 2003
231. “Modern Gonadotropins and Stimulations for ART”. Miami Area Reproductive Endocrinologists Quarterly Meeting. Ft. Lauderdale, Florida. May 7, 2003.
232.  "Ovarian Reserve Testing and Stimulation of the Poor Responder". 16th Annual IVF and Embryo Transfer. Annual Review Course in IVF, UCLA School of Medicine. July 12, 2003 
233. "Immunologic Testing and Treatment Before IVF - Evidence Not Empiricism". 16th Annual IVF and Embryo Transfer. . Annual Review Course in IVF, UCLA School of Medicine. July 15, 2003
234. “Clinical Aspects of Preimplantation Genetic Diagnosis, Where are We Now”, Annual Clinical Meeting of the American Society of Reproductive Medicine, San Antonio Texas, October 13, 2003
235.  “Contemporary Approaches to Optimizing Ovulation Induction”, Annual IVF Clinical Meeting, Xongxing, People’s Republic of China, December 16, 2003
236.  “The Future of IVF”, Annual IVF Clinical Meeting , Xongxing, People’s Republic of China, December 16, 2003
237.  “Preimplantation Genetic Diagnosis, Now and in the Future”, Organon’s Experts in Reproductive Medicine, Scottsdale, Arizona, February 20, 2004
238. “New Tests in Male Infertility”, Patient Friendly In-Vitro Fertilisation – Strategies to Make IVF Easier for Patients and Staff, Barbados, Eastern Caribbean, February 24, 2004
239. “Understanding and Screening for Reproductive Senescence”. Grand Rounds, St Louis University, St Louis, Missouri, March 18, 2004
240. “Contemporary Evaluation of Infertility”. Annual Obstetrics and Gynecology Review Course, St. Louis Missouri March 18, 2004
241. “The Clinical Role of LH in Different Protocols for Ovulation Induction" Houston Area Reproductive Endocrinologists, Houston, Texas, April 1, 2004
242. “Understanding Reproductive Senescence”, Grand Rounds, Houston Humana Women’s Hospital / OGA, Houston, Texas April 2, 2004
243. . “Contemporary Evaluation of Recurrent Pregnancy Loss”, Carolinas Medical Center Annual Review Course, Charlotte, North Carolina, May 21, 2004
244.  “Preimplantation Genetic Diagnosis: A Clinical Perspective”, Carolinas Medical Center Annual Review Course, Charlotte, North Carolina, May 22, 2004
245. “New Technologies in ART”, Connecticut Area Reproductive Endocrine Society (CARES), New Haven, Connecticut, April 15, 2004
246. “Evaluation of the Infertile Couple”, Post Graduate Course, Annual Clinical Meeting of the American College of Obstetrics and Gynecology, Philadelphia, Pennsylvania, May 1, 2004
247. “Ovarian Reserve Screening”, Post Graduate Course, Annual Clinical Meeting of the American College of Obstetrics and Gynecology, Philadelphia, Pennsylvania, May 1, 2004
248. “Recurrent Pregnancy Loss”, Post Graduate Course, Annual Clinical Meeting of the American College of Obstetrics and Gynecology, Philadelphia, Pennsylvania, May 2, 2004
249. “New Technologies for Reproductive Endocrinology and Infertility- What’s New and What’s Next?”, Post Graduate Course, Annual Clinical Meeting of the American College of Obstetrics and Gynecology, Philadelphia, Pennsylvania, May 2, 2004
250. “Laboratory Strategies for Improving Outcomes in ART”, Toronto Area Reproductive Endocrinologists (Serono sponsored dinner program), Toronto Canada, May 12, 2004
251. “Laboratory Strategies for Improving Outcomes in ART”, Vancouver Area Reproductive Endocrinologists (Serono sponsored dinner program), Vancouver Canada, May 13, 2004
252. “New Technologies for Future ART”, ICSI Meeting, European Society of Human Reproduction and Embryology Annual Meeting, Berlin, Germany, June 25, 2004
253.  “Predicting Treatment Response” and "Management of High & Low Responders in IVF” SMART ART. Las Vegas August 19-21, 2004
254. "Multiple gestation and ART" , Grand Rounds, Morristown Memorial Hospital, Morristown, New Jersey September 9, 2004